FilingReader Intelligence
Mankind Pharma board to consider interim dividend
July 14, 2025 at 04:49 PM UTC•By FilingReader AI
Mankind Pharma Limited's board will meet July 31 to approve unaudited financial results for the quarter ended June 30, 2025.
The board will also consider declaring an interim dividend for financial year 2025-26.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:MANKIND•Bombay Stock Exchange
News Alerts
Get instant email alerts when Mankind Pharma publishes news
Free account required • Unsubscribe anytime